Auffarth, Blumenkranz Named to Presbia Boards
DUBLIN, Aug. 5, 2015 — Presbia PLC, an ophthalmic device company, has appointed Dr. Gerd Auffarth to its Board of Directors and Dr. Mark Blumenkranz to its Medical Advisory Board. Dr. Auffarth is the director of the International Vision Correction Research Center and the David J. Apple International Laboratory for Ophthalmic Pathology. He conducts research in corneal surgery, presbyopia, cataracts and intraocular lens implants, and has expertise in IOLs, multi-focal IOLs, refractive laser technologies and